¼¼°èÀÇ ¸ð¼¼°ü Àü±â ¿µµ¿ ½ÃÀåÀº 2024³â 3¾ï 6,720¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2034³â¿¡´Â 6¾ï 3,310¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 5.6%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù. ÀÇ·á »ê¾÷ÀÌ º¸´Ù Á¤È®ÇÏ°í °³ÀÎÈµÈ µ¥ÀÌÅÍ ±â¹Ý Ä¡·á Á¢±Ù ¹æ½ÄÀ¸·Î ÀüȯÇÔ¿¡ µû¶ó ¸ð¼¼°ü Àü±â ¿µµ¿°ú °°Àº È¿À²ÀûÀÎ ºÐ¼® µµ±¸¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ ±â¼úÀº Å©±â¿Í ÀüÇÏ¿¡ µû¶ó ÀÛÀº ºÐÀÚ³ª ÀÌ¿ÂÀ» ºÐ¸®ÇÏ´Â Á¤¹Ðµµ°¡ ³ô¾Æ À¯ÀüÀÚ ºÐ¼®, Áúº´ Áø´Ü, Á¦¾à ¿¬±¸¿¡ ¸Å¿ì È¿°úÀûÀ̱⠶§¹®¿¡ °¢±¤¹Þ°í ÀÖ½À´Ï´Ù. À¯ÀüüÇÐ, ´Ü¹éÁúüÇÐ, ¹ýÀÇÇÐ ºÐ¾ß¿¡¼ Ȱ¿ëµµ°¡ ³ô¾ÆÁö¸é¼ ¸ð¼¼°ü Àü±â ¿µµ¿Àº Çаè, ÀÓ»ó ¹× »ê¾÷ ¿¬±¸ ȯ°æ¿¡¼ °è¼Ó ÁÖ¸ñÀ» ¹Þ°í ÀÖ½À´Ï´Ù.
¿¬±¸ÀÚ¿Í ÀÓ»óÀǵéÀº À¯ÀüÀÚ º¯À̸¦ ŽÁöÇÏ°í º´¿ø±ÕÀ» ¸ð´ÏÅ͸µÇÏ¸ç º¹ÀâÇÑ »ý¹°ÇÐÀû È¥ÇÕ¹°À» ºÐ¼®Çϱâ À§ÇØ ÀÌ ¹æ¹ý¿¡ Á¡Á¡ ´õ ÀÇÁ¸Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ´õ ³ªÀº Ç¥Àû Ä¡·á¹ýÀ» ¼ö¸³Çϰí Àü¹ÝÀûÀΠȯÀÚ Ä¡·á °á°ú¸¦ °³¼±ÇÏ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ R&D¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, ÷´Ü Áø´Ü ¹æ¹ý¿¡ ´ëÇÑ ±ÔÁ¦ Áö¿ø, Â÷¼¼´ë ½ÃÄö½Ì ¿öÅ©Ç÷ο쿡 ´ëÇÑ ÀÌ ±â¼úÀÇ ºü¸¥ ÅëÇÕÀ¸·Î ÀÎÇØ ½ÃÀåÀº °·ÂÇÑ ¸ð¸àÅÒÀ» ¸ñ°ÝÇϰí ÀÖ½À´Ï´Ù. Á¤¹Ð ÀÇÇп¡ ´ëÇÑ Àü ¼¼°èÀûÀÎ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¸ð¼¼°ü Àü±â ¿µµ¿Àº ºÐÀÚ Áø´Ü ŸŶÀÇ ÇʼöÀûÀÎ ºÎºÐÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§ | |
---|---|
½ÃÀÛ ¿¬µµ | 2024³â |
¿¹Ãø ¿¬µµ | 2025-2034³â |
½ÃÀÛ ±Ý¾× | 3¾ï 6,720¸¸ ´Þ·¯ |
¿¹Ãø ±Ý¾× | 6¾ï 3,310¸¸ ´Þ·¯ |
CAGR | 5.6% |
½ÃÀåÀº ±â±â, ¼Ò¸ðǰ, ¼ÒÇÁÆ®¿þ¾î·Î ¼¼ºÐȵ˴ϴÙ. ÀÌ Áß ¼Ò¸ðǰÀº 2024³â 2¾ï 1,650¸¸ ´Þ·¯·Î °¡Àå Å« ºñÁßÀ» Â÷ÁöÇßÀ¸¸ç, 2034³â±îÁö 5.4%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¸ð¼¼Ç÷°ü ¹× Ư¼ö ½Ã¾à°ú °°Àº ¼Ò¸ðǰÀº ±â¼úÀÇ ¹«°á¼º°ú ¼º´ÉÀ» À¯ÁöÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ½ÇÇè½Ç¿¡¼ Á¤È®ÇÑ °á°ú¸¦ º¸ÀåÇϱâ À§ÇØ ÀϰüµÈ °íǰÁú ¼Ò¸ðǰ¿¡ Å©°Ô ÀÇÁ¸Çϰí Àֱ⠶§¹®¿¡ ÀÌ ºÎ¹®Àº ÀÏ»óÀûÀÎ ¼ö¿ä¿¡ ÈûÀÔ¾î ²ÙÁØÇÑ ¼ºÀåÀ» À̾°í ÀÖ½À´Ï´Ù.
À¯Çüº°·Î ¸ð¼¼°ü °Ö Àü±â ¿µµ¿(CGE) ºÎ¹®Àº 2024³â 45.7%ÀÇ ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. CGE´Â DNA, RNA, ´Ü¹éÁú°ú °°Àº ´ëÇü »ýü ºÐÀÚ¸¦ ºÐ¸®ÇÏ´Â µ¥ ³Î¸® »ç¿ëµÇ¸ç À¯ÀüÀÚ ¿°±â¼¿ ºÐ¼®, µ¹¿¬º¯ÀÌ ºÐ¼®, ÇÁ·ÎÅ׿À¹Í½º¿¡ ³Î¸® »ç¿ëµÇ´Â ±â¼úÀÔ´Ï´Ù. ¸Å¿ì Á¤È®ÇÑ °á°ú¸¦ Á¦°øÇÏ´Â ´É·Â ´öºÐ¿¡ º¹ÀâÇÑ »ý¹°ÇÐÀû ÈÇÕ¹°À» ºÐ¸®ÇØ¾ß ÇÏ´Â ¿¬±¸ ¹× Áø´Ü ¾ÖÇø®ÄÉÀ̼ǿ¡ ¾ø¾î¼´Â ¾È µÉ Çʼö ¿ä¼ÒÀÔ´Ï´Ù.
¹Ì±¹ÀÇ ¸ð¼¼°ü Àü±â ¿µµ¿ ½ÃÀåÀº ƯÈ÷ Á¾¾çÇÐ ºÐ¾ß¿¡¼ Áúº´ Á¶±â ¹ß°ß¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÈûÀÔ¾î ºü¸£°Ô È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ±â¼úÀº ¾Ï°ú °ü·ÃµÈ À¯ÀüÀÚ ¸¶Ä¿ÀÇ °íÇØ»óµµ ºÐ¼®À» °¡´ÉÇÏ°Ô ÇÏ¿© °³ÀÎ ¸ÂÃãÇü Ä¡·á °èȹÀÇ °³¹ßÀ» ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù. ¼±µµÀûÀÎ ¿¬±¸ ±â°üÀÇ Áö¼ÓÀûÀÎ Çõ½ÅÀ¸·Î ƯÈ÷ ¹ÙÀÌ¿À¸¶Ä¿ ½Äº° ºÐ¾ß¿¡¼ ±â¼úÀÇ Á¤¹Ðµµ°¡ Çâ»óµÇ°í ÀÖ½À´Ï´Ù.
Thermo Fisher Scientific, QIAGEN, Bio-Techne ¹× Agilent Technologies¿Í °°Àº ÁÖ¿ä ±â¾÷µéÀº Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ ¹ßÀü½ÃŰ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¾÷µéÀº ±â±âÀÇ °¨µµ¸¦ ³ôÀÌ°í ¼Ò¸ðǰ ¼º´ÉÀ» °³¼±ÇÏ¸ç °³ÀÎ ¸ÂÃãÇü ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ¹ß¸ÂÃç ÅëÇÕ ½Ã½ºÅÛÀ» µµÀÔÇϱâ À§ÇÑ Çù¾÷À» Ãß±¸Çϰí ÀÖ½À´Ï´Ù.
The Global Capillary Electrophoresis Market was valued at USD 367.2 million in 2024 and is estimated to grow at a CAGR of 5.6% to reach USD 633.1 million by 2034. As the healthcare industry shifts toward more accurate, personalized, and data-driven treatment approaches, the demand for efficient analytical tools like capillary electrophoresis is on the rise. This technology is gaining ground due to its high precision in separating small molecules or ions based on size and charge, which makes it exceptionally effective for genetic analysis, disease diagnostics, and pharmaceutical research. With growing applications in genomics, proteomics, and forensic science, capillary electrophoresis continues to attract attention across academic, clinical, and industrial research landscapes.
Researchers and clinicians are increasingly leaning on this method to detect genetic mutations, monitor pathogens, and analyze complex biological mixtures, which is helping them formulate better-targeted therapies and improve overall patient outcomes. The market is also witnessing strong momentum due to rising investments in R&D, regulatory support for advanced diagnostic methods, and the rapid integration of this technology into next-generation sequencing workflows. As global demand for precision medicine grows, capillary electrophoresis is emerging as an indispensable part of the molecular diagnostics toolkit.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $367.2 Million |
Forecast Value | $633.1 Million |
CAGR | 5.6% |
The market is segmented into instruments, consumables, and software. Among these, consumables held a significant share, generating USD 216.5 million in 2024, and are expected to expand at a CAGR of 5.4% through 2034. Consumables such as capillaries and specialized reagents are critical to maintaining the integrity and performance of the technique. With laboratories relying heavily on consistent, high-quality consumables to ensure accurate results, this segment continues to see steady growth driven by routine demand.
Based on type, the capillary gel electrophoresis (CGE) segment accounted for a 45.7% market share in 2024. CGE is widely used to separate large biomolecules like DNA, RNA, and proteins, making it a go-to technique for genetic sequencing, mutation analysis, and proteomics. Its ability to deliver highly accurate results makes it indispensable for research and diagnostic applications that require the separation of complex biological compounds.
The U.S. Capillary Electrophoresis Market is expanding rapidly, driven by rising demand for early disease detection, especially in oncology. The technique enables high-resolution analysis of genetic markers linked to cancer, facilitating the development of personalized treatment plans. Ongoing innovations from leading research institutions are enhancing the technique's precision, particularly in biomarker identification.
Leading players, including Thermo Fisher Scientific, QIAGEN, Bio-Techne, and Agilent Technologies, are focused on advancing their product portfolios. These companies are enhancing instrument sensitivity, improving consumable performance, and pursuing collaborations to introduce integrated systems that align with the growing need for personalized healthcare solutions.